The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
04/15/2021 | Thomas B “Brad” Gold
Why multilayer tablets, multiparticulates, and mini tablets could lead the way in patient-centric drug delivery.
04/09/2021 | Maryam Mahdi
Is there a place for traditional medicines in the pharmaceutical industry?
04/08/2021 | Maryam Mahdi
New guidance on the use of whey and lactose-derived products in pharmaceuticals.
03/26/2021 | Mary Medeiros
Suppliers of reagents and buffers need to adhere to quality systems.
02/09/2021 | Alice Dunbabin
Biocatalysis is an increasingly attractive option in pharmaceutical synthesis.
12/08/2020 | Philip Wheeler, Dirk Rickert, Thorsten Rieke
Platinum group (and other precious) metal catalysts are inherently expensive, so why not recover and recycle?
11/03/2020 | Maryam Mahdi
How can companies avoid the risks of HPAPI containment and handling?
09/08/2020 | Maryam Mahdi
How is the Indian pharmaceutical industry adapting to meet new demands?
08/21/2020 | Maryam Mahdi
Newly published research suggests that some excipients may be more "active" than previously thought.
08/19/2020 | Stephanie Sutton
Can a medieval medicament find use as a modern antibacterial?
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
The Grand Winner
How Data Sharing Can Upgrade AI for Pharma
Welcome to the CRISPR Powerhouse